Randomized trial · people

GHK-Cu gel: 98.5% median closure of diabetic plantar ulcers vs 60.8%

Checked against the paper Randomized trialPublished by PepVault

The takeaway

This is a controlled human trial in which a topical GHK-Cu gel helped diabetic plantar ulcers close more fully than a vehicle gel when added to standard wound care.

Kind
Randomized trial
Studied in
People
Published
1994
Journal
Wound Repair Regen

What they tested

The team tested whether a topical GHK-Cu gel, called lamin Gel, is safe and helps diabetic nerve-damage ulcers heal.

How the study was done

A multicenter, randomized, placebo-controlled trial in patients with diabetic neuropathic ulcers, with evaluators blinded to treatment. All patients also got intensive standard wound care: removal of dead tissue (debridement) at entry, offloading footwear and education, with the GHK-Cu gel or a vehicle (the gel base without the active compound) applied daily.

A woman in glasses at a kitchen table with a laptop, a mug and her phone

PepVault for iPhone

Taking GHK-Cu? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

What they found

Plantar ulcers, those on the sole of the foot, treated with GHK-Cu gel reached a median 98.5% closure of their area, compared with 60.8% for vehicle (p < 0.05), and more patients healed 98% or better. Ulcers also closed faster with the gel than with standard care and vehicle. In larger ulcers, over 100 mm(2) at entry, median closure was 89.2% with the gel versus -10.3% with vehicle (p < 0.01). When the gel was started right after debridement, ulcer infections occurred in 7% versus 34% with vehicle (p < 0.05).

What it doesn’t show

The gel was tested on top of an intensive wound care program, and the best results depended on starting it right after debridement. The larger-ulcer and infection results come from subgroups, and only diabetic neuropathic ulcers were studied.

The paper

Mulder et al. Enhanced healing of ulcers in patients with diabetes by topical treatment with glycyl-l-histidyl-l-lysine copper. Wound Repair Regen. 1994.

The compound

More studies on GHK-Cu

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.

Track it in the app

PepVault for iPhone

Taking GHK-Cu? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo